新基制药(CELG)

108.24 0.00 0.0%

今开:0.0昨收:108.24
最高:0.0 最低:0.0
涨停价:0.0跌停价:0.0
总市值:7.7035975315E10

新基制药的最新讨论

davidweng2017-10-26 23:39

这波美股热门股杀跌不一般那,从中概股到生物科技,只要业绩稍微不如意,毫不留情的杀。刚在听CNBC,现在市场已经转成“earning beat”只涨一点点,“earning miss”就暴跌的“不安模式”,看起来接下来这段时间不会很好过。$新基制药(CELG)$ $好未来(TAL)$查看全文

Alwaleed2017-10-26 23:37

$新基制药(CELG)$ 奇葩的走势,各种低开。查看全文

Arthur_L2017-10-26 23:08

$新基制药(CELG)$ 加仓的良机!查看全文

tiger-in-motion2017-10-26 22:49

$新基制药(CELG)$ 除了再做一笔大的DEAL 或者OTEZLA 又有新的LABEL INDICATION.否则股价最多到110查看全文

尋找52_week_high2017-10-26 21:57

$新基制药(CELG)$ 新基都可以这样跌,买药股真的要审慎查看全文

抄作业的Jack2017-10-26 21:37

$长城汽车(02333)$ 明天应该会比$好未来(TAL)$ $新基制药(CELG)$ 表现好一些吧。查看全文

dudumr2017-10-26 21:01

[关灯吃面][好失望] $新基制药(CELG)$ 这个月最的操作,出了TWTR,入了CELG!!!脑子进屎了查看全文

非洲人咸猪手2017-10-26 20:49

$新基制药(CELG)$ 这跌幅厉害了、看情况决定接不接飞刀[害羞]查看全文

割资本主义羊毛2017-10-26 20:41

$新基制药(CELG)$ 本轮生技的最大泡沫股终于开始有点刺破迹象了,两年来在不断质疑声中股价反创新高,埋下的若干地雷,终于在本次财报炸响第一颗。查看全文

1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60 61 62 63 64 65 66 67 68 69 70

新基制药的公告

$新基制药(CELG)$ SC 13G/A [Amend] Statement of acquisition of beneficial ownership by individuals Accession Number: 0001104659-20-013792  Size: 69 KB 网页链接

$新基制药(CELG)$ SC 13G Statement of acquisition of beneficial ownership by individuals Accession Number: 0001104659-20-013796  Size: 42 KB 网页链接

$新基制药(CELG)$ 15-12B Securities registration termination [Section 12(b)] Accession Number: 0001140361-19-022527  Act: 34  Size: 15 KB 网页链接

$新基制药(CELG)$ S-4 POS Securities issued, formation of bank or savings and loan holding company [General Instruction G], post-effective amendments Accession Number: 0001140361-19-022225  Act: 33  Size: 20 KB 网页链接

$新基制药(CELG)$ S-4 POS Securities issued, formation of bank or savings and loan holding company [General Instruction G], post-effective amendments Accession Number: 0001140361-19-022228  Act: 33  Size: 20 KB 网页链接

$新基制药(CELG)$ S-4 POS Securities issued, formation of bank or savings and loan holding company [General Instruction G], post-effective amendments Accession Number: 0001140361-19-022200  Act: 33  Size: 20 KB 网页链接

$新基制药(CELG)$ S-8 POS Securities to be offered to employees in employee benefit plans, post-effective amendments Accession Number: 0001140361-19-022201  Act: 33  Size: 39 KB 网页链接

$新基制药(CELG)$ S-8 POS Securities to be offered to employees in employee benefit plans, post-effective amendments Accession Number: 0001140361-19-022206  Act: 33  Size: 39 KB 网页链接

$新基制药(CELG)$ S-8 POS Securities to be offered to employees in employee benefit plans, post-effective amendments Accession Number: 0001140361-19-022210  Act: 33  Size: 39 KB 网页链接

$新基制药(CELG)$ S-8 POS Securities to be offered to employees in employee benefit plans, post-effective amendments Accession Number: 0001140361-19-022217  Act: 33  Size: 39 KB 网页链接

1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60 61 62 63 64 65 66 67 68 69 70 71 72 73 74